002589-基本财务实时评分详情
瑞康医药002589基本财务实时评分详情
更新时间:2021-12-06 00:00:01
股票代码
002589
当期评分
股票名称
瑞康医药
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)-0.11261.3920.20140.20140.2014
销售净利润率(%)3.7673-1.23373.16083.16083.1608
销售毛利率(%)18.774118.937818.652318.652318.6523
净资产收益率(%)9.21-12.914.124.124.12
营业增长率(%)45.6133.9506-25.7558-25.7558-25.7558
净利润增长率(%)-6.6242-134.0412-33.0806-33.0806-33.0806
每股收益(%)0.517-0.620.140.060.205
现金流量比率(%)-0.796410.1380.91590.72881.3458
三项费用比重(%)12.566713.979514.224314.365314.4126
每股净资产(¥)5.61664.7764.91584.83954.9812
流动比率(%)1.34721.34351.26281.32851.2689
速动比率(%)1.13561.1671.12551.16651.1348
现金比率(%)14.423423.380427.239730.712230.7122
总资产利润率(%)4.134-1.29261.20520.48111.9209
主营利润比重%324.45696522.2414442.2249582.7824426.0467
应收账款(万元)1,716,262.431,563,858.131,515,435.021,499,779.791,530,861.63
应收票据(万元)81,724.6414,200.4815,033.378,756.6525,862.13
预付款项(万元)150,387.44117,859.17132,232.87129,011.59135,031.22
存货(万元)450,202.86364,760.39308,650.21357,765.56302,086.56
在建工程(万元)49,469.5778,059.7694,402.7281,601.3495,116.82
应付款项(万元)551,881.79530,350.15446,968.53495,889.07511,880.89
长期借款(万元)22,544.772,676.154,957.603,640.203,270.00
未分配利润(万元)285,613.22183,475.75204,505.78193,036.27214,347.67
商誉(万元)330,840.95126,391.5385,780.02125,041.0584,782.15
流动资产(万元)617,613.12470,805.00481,745.85483,748.99479,986.94
流动负债(万元)2,127,371.912,066,009.292,248,158.602,208,590.402,251,515.89
瑞康医药002589评分结果
60.61分
卖出/减持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006